Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes
Abstract Background Monocytes play an important role in innate immunity and exhibit prognostic value in some cancers. It was hypothesised that activation of the innate immune system through mobilisation of monocytes to tissue macrophages develops an inflammatory state associated with increased risk...
Gespeichert in:
Veröffentlicht in: | European journal of cancer (1990) 2011-09, Vol.47 (13), p.2015-2022 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2022 |
---|---|
container_issue | 13 |
container_start_page | 2015 |
container_title | European journal of cancer (1990) |
container_volume | 47 |
creator | Sajadieh, Ahmad Mouridsen, Mette R Selmer, Christian Intzilakis, Theodoros Nielsen, Olav W Haugaard, Steen B |
description | Abstract Background Monocytes play an important role in innate immunity and exhibit prognostic value in some cancers. It was hypothesised that activation of the innate immune system through mobilisation of monocytes to tissue macrophages develops an inflammatory state associated with increased risk of cancer and mortality. Methods To test this hypothesis monocyte number was measured in a sample of 669 Danish men (59%) and women (41%) aged 55 to 75 years who were free of any known prevalent cancer or cardiovascular disease. The population was followed for 6.3 years, during which period incident cancers and deaths were compiled from validated national registries. Results Fifty-two subjects developed cancer and 83 subjects died during follow-up. The upper quintile of monocyte number (median 0.44 × 109 /L, lower quintile 0.60) was associated with an increased risk of cancer (hazard ratio [HR] 2.00 [95% CI 1.12–3.57]) and deaths (HR 1.67 [1.03–2.72]) in univariate analyses, after correction for age and gender (cancer HR 2.15 [1.20–3.86] and death HR 1.63 [1.00–2.67]), and following additional correction for smoking habits, diabetes, systolic blood pressure, and total cholesterol (cancer HR 2.00 [1.10–3.70] and death HR 1.30 [0.78–2.16]). COX regression models, with inclusion of the aforementioned explanatory variables and added heart rate variability, alcohol use, and CRP, revealed monocyte count (per 0.1 × 109 /L increase) to be independently associated with incident cancer (HR 1.12 (1.05–1.19)) and death (HR 1.13 (1.06–1.19)). Conclusions In healthy middle-aged and elderly community-dwelling Danes circulating monocytes independently predicted incident cancer and mortality. |
doi_str_mv | 10.1016/j.ejca.2011.02.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_884845211</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804911001353</els_id><sourcerecordid>884845211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-171a0d4528f8e865f59b9362b36161c62e1eddaff19153422f8659d9ce6148013</originalsourceid><addsrcrecordid>eNp9ks-L1TAQx4Mo7nP1H_AgvYin1kya9iUgwrL-hBUP6jnkJdM1tU12k9Sl_70p76ngwdMc5vOdGT4MIU-BNkChfzk2OBrdMArQUNZQ6O6RHYi9rKno2H2yo7KTtaBcnpFHKY2U0r3g9CE5Y8BbKUDsyO2n4INZM1Z-mQ8YK51SME5ntNWdy98r542z6HNltDdb39tqDjHryeW1dKvZWTthra9LYmviZDFOa2XCPC--QLW9w2ly_rp6oz2mx-TBoKeET071nHx79_br5Yf66vP7j5cXV7XhnOYa9qCp5R0Tg0DRd0MnD7Lt2aHtoQfTMwS0Vg8DSOhazthQIGmlwR64oNCekxfHuTcx3C6YsppdMuWSckRYkhKCizIeNpIdSRNDShEHdRPdrOOqgKrNtBrVZlptphVlqpguoWen8cthRvsn8lttAZ6fAJ2MnoZY_Ln0l-MdFXuxbX915LDI-OkwqmQcFtfWRTRZ2eD-f8frf-KmuHZl4w9cMY1hib5oVqBSCagv209sLwFAi6SubX8Bzhmxgw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>884845211</pqid></control><display><type>article</type><title>Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Sajadieh, Ahmad ; Mouridsen, Mette R ; Selmer, Christian ; Intzilakis, Theodoros ; Nielsen, Olav W ; Haugaard, Steen B</creator><creatorcontrib>Sajadieh, Ahmad ; Mouridsen, Mette R ; Selmer, Christian ; Intzilakis, Theodoros ; Nielsen, Olav W ; Haugaard, Steen B</creatorcontrib><description>Abstract Background Monocytes play an important role in innate immunity and exhibit prognostic value in some cancers. It was hypothesised that activation of the innate immune system through mobilisation of monocytes to tissue macrophages develops an inflammatory state associated with increased risk of cancer and mortality. Methods To test this hypothesis monocyte number was measured in a sample of 669 Danish men (59%) and women (41%) aged 55 to 75 years who were free of any known prevalent cancer or cardiovascular disease. The population was followed for 6.3 years, during which period incident cancers and deaths were compiled from validated national registries. Results Fifty-two subjects developed cancer and 83 subjects died during follow-up. The upper quintile of monocyte number (median 0.44 × 109 /L, lower quintile <0.33, upper quintile >0.60) was associated with an increased risk of cancer (hazard ratio [HR] 2.00 [95% CI 1.12–3.57]) and deaths (HR 1.67 [1.03–2.72]) in univariate analyses, after correction for age and gender (cancer HR 2.15 [1.20–3.86] and death HR 1.63 [1.00–2.67]), and following additional correction for smoking habits, diabetes, systolic blood pressure, and total cholesterol (cancer HR 2.00 [1.10–3.70] and death HR 1.30 [0.78–2.16]). COX regression models, with inclusion of the aforementioned explanatory variables and added heart rate variability, alcohol use, and CRP, revealed monocyte count (per 0.1 × 109 /L increase) to be independently associated with incident cancer (HR 1.12 (1.05–1.19)) and death (HR 1.13 (1.06–1.19)). Conclusions In healthy middle-aged and elderly community-dwelling Danes circulating monocytes independently predicted incident cancer and mortality.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2011.02.015</identifier><identifier>PMID: 21439818</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Aged ; Biological and medical sciences ; Community ; Denmark - epidemiology ; Epidemiology ; Female ; Follow-Up Studies ; Hematology, Oncology and Palliative Medicine ; Humans ; Incident cancer ; Low-grade inflammation ; Male ; Medical sciences ; Middle Aged ; Monocyte number ; Monocytes - immunology ; Mortality ; Neoplasms - epidemiology ; Neoplasms - immunology ; Neoplasms - mortality ; Pharmacology. Drug treatments ; Tumors</subject><ispartof>European journal of cancer (1990), 2011-09, Vol.47 (13), p.2015-2022</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-171a0d4528f8e865f59b9362b36161c62e1eddaff19153422f8659d9ce6148013</citedby><cites>FETCH-LOGICAL-c440t-171a0d4528f8e865f59b9362b36161c62e1eddaff19153422f8659d9ce6148013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejca.2011.02.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24508781$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21439818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sajadieh, Ahmad</creatorcontrib><creatorcontrib>Mouridsen, Mette R</creatorcontrib><creatorcontrib>Selmer, Christian</creatorcontrib><creatorcontrib>Intzilakis, Theodoros</creatorcontrib><creatorcontrib>Nielsen, Olav W</creatorcontrib><creatorcontrib>Haugaard, Steen B</creatorcontrib><title>Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Abstract Background Monocytes play an important role in innate immunity and exhibit prognostic value in some cancers. It was hypothesised that activation of the innate immune system through mobilisation of monocytes to tissue macrophages develops an inflammatory state associated with increased risk of cancer and mortality. Methods To test this hypothesis monocyte number was measured in a sample of 669 Danish men (59%) and women (41%) aged 55 to 75 years who were free of any known prevalent cancer or cardiovascular disease. The population was followed for 6.3 years, during which period incident cancers and deaths were compiled from validated national registries. Results Fifty-two subjects developed cancer and 83 subjects died during follow-up. The upper quintile of monocyte number (median 0.44 × 109 /L, lower quintile <0.33, upper quintile >0.60) was associated with an increased risk of cancer (hazard ratio [HR] 2.00 [95% CI 1.12–3.57]) and deaths (HR 1.67 [1.03–2.72]) in univariate analyses, after correction for age and gender (cancer HR 2.15 [1.20–3.86] and death HR 1.63 [1.00–2.67]), and following additional correction for smoking habits, diabetes, systolic blood pressure, and total cholesterol (cancer HR 2.00 [1.10–3.70] and death HR 1.30 [0.78–2.16]). COX regression models, with inclusion of the aforementioned explanatory variables and added heart rate variability, alcohol use, and CRP, revealed monocyte count (per 0.1 × 109 /L increase) to be independently associated with incident cancer (HR 1.12 (1.05–1.19)) and death (HR 1.13 (1.06–1.19)). Conclusions In healthy middle-aged and elderly community-dwelling Danes circulating monocytes independently predicted incident cancer and mortality.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Community</subject><subject>Denmark - epidemiology</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Incident cancer</subject><subject>Low-grade inflammation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monocyte number</subject><subject>Monocytes - immunology</subject><subject>Mortality</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - mortality</subject><subject>Pharmacology. Drug treatments</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks-L1TAQx4Mo7nP1H_AgvYin1kya9iUgwrL-hBUP6jnkJdM1tU12k9Sl_70p76ngwdMc5vOdGT4MIU-BNkChfzk2OBrdMArQUNZQ6O6RHYi9rKno2H2yo7KTtaBcnpFHKY2U0r3g9CE5Y8BbKUDsyO2n4INZM1Z-mQ8YK51SME5ntNWdy98r542z6HNltDdb39tqDjHryeW1dKvZWTthra9LYmviZDFOa2XCPC--QLW9w2ly_rp6oz2mx-TBoKeET071nHx79_br5Yf66vP7j5cXV7XhnOYa9qCp5R0Tg0DRd0MnD7Lt2aHtoQfTMwS0Vg8DSOhazthQIGmlwR64oNCekxfHuTcx3C6YsppdMuWSckRYkhKCizIeNpIdSRNDShEHdRPdrOOqgKrNtBrVZlptphVlqpguoWen8cthRvsn8lttAZ6fAJ2MnoZY_Ln0l-MdFXuxbX915LDI-OkwqmQcFtfWRTRZ2eD-f8frf-KmuHZl4w9cMY1hib5oVqBSCagv209sLwFAi6SubX8Bzhmxgw</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Sajadieh, Ahmad</creator><creator>Mouridsen, Mette R</creator><creator>Selmer, Christian</creator><creator>Intzilakis, Theodoros</creator><creator>Nielsen, Olav W</creator><creator>Haugaard, Steen B</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes</title><author>Sajadieh, Ahmad ; Mouridsen, Mette R ; Selmer, Christian ; Intzilakis, Theodoros ; Nielsen, Olav W ; Haugaard, Steen B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-171a0d4528f8e865f59b9362b36161c62e1eddaff19153422f8659d9ce6148013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Community</topic><topic>Denmark - epidemiology</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Incident cancer</topic><topic>Low-grade inflammation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monocyte number</topic><topic>Monocytes - immunology</topic><topic>Mortality</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - mortality</topic><topic>Pharmacology. Drug treatments</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sajadieh, Ahmad</creatorcontrib><creatorcontrib>Mouridsen, Mette R</creatorcontrib><creatorcontrib>Selmer, Christian</creatorcontrib><creatorcontrib>Intzilakis, Theodoros</creatorcontrib><creatorcontrib>Nielsen, Olav W</creatorcontrib><creatorcontrib>Haugaard, Steen B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sajadieh, Ahmad</au><au>Mouridsen, Mette R</au><au>Selmer, Christian</au><au>Intzilakis, Theodoros</au><au>Nielsen, Olav W</au><au>Haugaard, Steen B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>47</volume><issue>13</issue><spage>2015</spage><epage>2022</epage><pages>2015-2022</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Abstract Background Monocytes play an important role in innate immunity and exhibit prognostic value in some cancers. It was hypothesised that activation of the innate immune system through mobilisation of monocytes to tissue macrophages develops an inflammatory state associated with increased risk of cancer and mortality. Methods To test this hypothesis monocyte number was measured in a sample of 669 Danish men (59%) and women (41%) aged 55 to 75 years who were free of any known prevalent cancer or cardiovascular disease. The population was followed for 6.3 years, during which period incident cancers and deaths were compiled from validated national registries. Results Fifty-two subjects developed cancer and 83 subjects died during follow-up. The upper quintile of monocyte number (median 0.44 × 109 /L, lower quintile <0.33, upper quintile >0.60) was associated with an increased risk of cancer (hazard ratio [HR] 2.00 [95% CI 1.12–3.57]) and deaths (HR 1.67 [1.03–2.72]) in univariate analyses, after correction for age and gender (cancer HR 2.15 [1.20–3.86] and death HR 1.63 [1.00–2.67]), and following additional correction for smoking habits, diabetes, systolic blood pressure, and total cholesterol (cancer HR 2.00 [1.10–3.70] and death HR 1.30 [0.78–2.16]). COX regression models, with inclusion of the aforementioned explanatory variables and added heart rate variability, alcohol use, and CRP, revealed monocyte count (per 0.1 × 109 /L increase) to be independently associated with incident cancer (HR 1.12 (1.05–1.19)) and death (HR 1.13 (1.06–1.19)). Conclusions In healthy middle-aged and elderly community-dwelling Danes circulating monocytes independently predicted incident cancer and mortality.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21439818</pmid><doi>10.1016/j.ejca.2011.02.015</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8049 |
ispartof | European journal of cancer (1990), 2011-09, Vol.47 (13), p.2015-2022 |
issn | 0959-8049 1879-0852 |
language | eng |
recordid | cdi_proquest_miscellaneous_884845211 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Aged Biological and medical sciences Community Denmark - epidemiology Epidemiology Female Follow-Up Studies Hematology, Oncology and Palliative Medicine Humans Incident cancer Low-grade inflammation Male Medical sciences Middle Aged Monocyte number Monocytes - immunology Mortality Neoplasms - epidemiology Neoplasms - immunology Neoplasms - mortality Pharmacology. Drug treatments Tumors |
title | Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T10%3A55%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monocyte%20number%20associated%20with%20incident%20cancer%20and%20mortality%20in%20middle-aged%20and%20elderly%20community-dwelling%20Danes&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Sajadieh,%20Ahmad&rft.date=2011-09-01&rft.volume=47&rft.issue=13&rft.spage=2015&rft.epage=2022&rft.pages=2015-2022&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2011.02.015&rft_dat=%3Cproquest_cross%3E884845211%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=884845211&rft_id=info:pmid/21439818&rft_els_id=S0959804911001353&rfr_iscdi=true |